{"transactions":[{"id":1041998,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:20:37.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":5.29,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114652","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114652/ownership.xml","form_type":"4"}},{"id":1041997,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:20:37.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":5.46,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114652","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114652/ownership.xml","form_type":"4"}},{"id":1041996,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:20:37.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":16.6,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114652","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114652/ownership.xml","form_type":"4"}},{"id":1041995,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:20:37.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":23.3,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114652","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114652/ownership.xml","form_type":"4"}},{"id":1041994,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T20:20:37.000Z","date":"2025-09-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"kind","element":"transactionCoding","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, prior to the expiration of the tender offer, the vesting or payment of each option to purchase shares outstanding under the Issuer's 2000 Stock Plan, as amended (the \"Issuer Stock Plan\") (each, an \"Issuer Option\"), that had a per share exercise price that was less than the Cash Amount was accelerated. With respect to the shares received upon exercise of such accelerated Issuer Options prior to the Effective Time, all such shares were treated identically with all other shares in connection with the tender offer and the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from footnote 3) At the Effective Time, each Issuer Option that had a per share exercise price that was equal to or greater than the Cash Amount, and that was unexercised immediately prior to the Effective Time, was canceled in connection with the Merger. Following the cancellation of each such Issuer Option, each former holder of such Issuer Option is eligible to receive a cash retention bonus subject to the achievement of certain net sales milestones, pursuant to a retention plan approved by the compensation committee of the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":5.68,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000950170-25-114652","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114652/ownership.xml","form_type":"4"}},{"id":1041993,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T20:20:37.000Z","date":"2025-09-11","kind":"other","planned":false,"acquired":false,"shares":15500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the terms of an Agreement and Plan of Merger, dated as of July 28, 2025 (as amended, the \"Merger Agreement\"), by and among the Issuer, Bausch Health Americas, Inc. (\"Parent\"), BHC Lyon Merger Sub, Inc., a direct wholly owned subsidiary of Parent (\"Purchaser\"), and solely for the purposes of Section 6.10 of the Merger Agreement, Bausch Health Companies Inc. (\"BHC\"), Purchaser completed a tender offer for shares of the Issuer's Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1) Tendering stockholders received a consideration of $1.75 per share, net to the seller of such shares in cash, without interest thereon and less any applicable withholding taxes (the \"Cash Amount\"), plus one non-tradeable contingent value right per share, representing the contractual right to receive the pro rata portion, in cash, of two milestone payments of up to $350,000,000 in the aggregate, minus any amount actually paid to option holders under a retention plan in respect of the applicable milestone, in each case, without interest thereon and less any applicable withholding taxes, upon achievement of the specified milestones. After completion of the tender offer, Purchaser merged with and into the Issuer (the \"Merger\"), effective as of September 11, 2025 (the \"Effective Time\"), with the Issuer continuing as the surviving entity and a wholly owned subsidiary of Parent."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-114652","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114652/ownership.xml","form_type":"4"}},{"id":1043256,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-11T18:00:13.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to this option grant shall vest and become exercisable on the day before the first anniversary of the date of grant, subject to the Reporting Person continuing to provide services to the Company through the vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.22,"expiration_date":"2034-09-25","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-114319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114319/ownership.xml","form_type":"4"}},{"id":1043255,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T18:00:13.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"price":1.22,"value":6710.0,"ownership":{"direct":true},"balance_after":15500,"source":{"system":"sec-edgar","filing":"0000950170-25-114319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017025114319/ownership.xml","form_type":"4"}},{"id":1398665,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-27T16:17:16.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to this option grant shall vest and become exercisable on the day before the first anniversary of the date of grant, subject to the Reporting Person continuing to provide services to the Company through the vesting date."}],"balance_after":5500,"derivative":{"exercise_price":1.22,"expiration_date":"2034-09-25","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-110016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000095017024110016/ownership.xml","form_type":"4"}},{"id":1796252,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrants to purchase Common Shares","published_at":"2023-08-25T20:19:41.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":53192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 53,192 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 53,192 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."}],"balance_after":53192,"derivative":{"exercise_price":1.75,"exercise_date":"2024-02-21","expiration_date":"2029-02-21","underlying":"Common Shares","underlying_shares":53192},"source":{"system":"sec-edgar","filing":"0000950170-23-044583","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000095017023044583/ownership.xml","form_type":"4"}},{"id":1796251,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-08-25T20:19:41.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":53192,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 53,192 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the \"Offering\"), the Reporting Person acquired 53,192 common share units (each, a \"Common Share Unit\"), each unit consisting of one of the Company's common shares, no par value (the \"Common Shares\"), and one warrant to purchase one Common Share.  The purchase price for each Common Share Unit was $1.88 per Common Share Unit."}],"balance_after":55192,"source":{"system":"sec-edgar","filing":"0000950170-23-044583","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000095017023044583/ownership.xml","form_type":"4"}},{"id":1845632,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T17:31:01.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 21, 2023 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":5500,"derivative":{"exercise_price":5.29,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-23-039470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919123039470/doc4.xml","form_type":"4"}},{"id":1861757,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T16:28:51.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":17643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 6, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17643,"derivative":{"exercise_price":1.09,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":17643},"source":{"system":"sec-edgar","filing":"0001127602-23-018286","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1614780/000112760223018286/form4.xml","form_type":"4"}},{"id":2083535,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-12-16T20:30:54.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":1000,"price":4.94,"value":4940.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001374339-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000137433922000004/primary_doc.xml","form_type":"4"}},{"id":2092118,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share","published_at":"2022-12-08T22:24:11.000Z","date":"2022-12-06","kind":"purchase","acquired":true,"shares":1000,"price":5.7,"value":5700.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001374339-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000137433922000003/primary_doc.xml","form_type":"4"}},{"id":2153994,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option (right to buy)","published_at":"2022-09-20T20:57:37.000Z","date":"2022-09-19","kind":"grant","acquired":true,"shares":208334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Conversion or exercise price is in Canadian dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option agreement provides that the option vests 25% on the one year anniversary of grant and the balance vests ratably over 36 months."}],"balance_after":208334,"derivative":{"exercise_price":7.1,"expiration_date":"2032-09-19","underlying":"Common Shares","underlying_shares":208334},"source":{"system":"sec-edgar","filing":"0001062993-22-019774","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000106299322019774/form4.xml","form_type":"4"}},{"id":2228639,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T16:09:24.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 15, 2022 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":55000,"derivative":{"exercise_price":0.5463,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-22-037827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122037827/doc4.xml","form_type":"4"}},{"id":2235336,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T16:39:28.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1614780/000112760222017243/form4.xml","form_type":"4"}},{"id":2235335,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T16:39:28.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":17478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17478,"derivative":{"exercise_price":1.06,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":17478},"source":{"system":"sec-edgar","filing":"0001127602-22-017243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1614780/000112760222017243/form4.xml","form_type":"4"}},{"id":2266286,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:35:30.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":29911,"price":0.4079,"value":12200.6969,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.4023 to $0.4136 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001209191-22-030286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122030286/doc4.xml","form_type":"4"}},{"id":2266285,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-18T20:35:30.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":25300,"price":0.3878,"value":9811.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.3734 to $0.4150 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":70089,"source":{"system":"sec-edgar","filing":"0001209191-22-030286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122030286/doc4.xml","form_type":"4"}},{"id":2272556,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T21:07:36.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":9250,"price":0.4,"value":3700.0,"ownership":{"direct":true},"balance_after":44789,"source":{"system":"sec-edgar","filing":"0001209191-22-029017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122029017/doc4.xml","form_type":"4"}},{"id":2272555,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T21:07:36.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":1500,"price":0.39,"value":585.0,"ownership":{"direct":true},"balance_after":35539,"source":{"system":"sec-edgar","filing":"0001209191-22-029017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122029017/doc4.xml","form_type":"4"}},{"id":2272554,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T21:07:36.000Z","date":"2022-05-11","kind":"purchase","acquired":true,"shares":9950,"price":0.3993,"value":3973.035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.37 to $0.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":34039,"source":{"system":"sec-edgar","filing":"0001209191-22-029017","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122029017/doc4.xml","form_type":"4"}},{"id":2273907,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-12T20:32:13.000Z","date":"2022-05-10","kind":"purchase","acquired":true,"shares":2339,"price":0.406,"value":949.634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.3949 to $0.4179 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":24089,"source":{"system":"sec-edgar","filing":"0001209191-22-028700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122028700/doc4.xml","form_type":"4"}},{"id":2276555,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-10T21:12:07.000Z","date":"2022-05-10","kind":"purchase","acquired":true,"shares":4250,"price":0.395,"value":1678.75,"ownership":{"direct":true},"balance_after":21750,"source":{"system":"sec-edgar","filing":"0001209191-22-028186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122028186/doc4.xml","form_type":"4"}},{"id":2276554,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-10T21:12:07.000Z","date":"2022-05-09","kind":"purchase","acquired":true,"shares":17500,"price":0.3946,"value":6905.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions. Prices ranged from $0.392 to $0.4078 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001209191-22-028186","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919122028186/doc4.xml","form_type":"4"}},{"id":2341601,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":40187,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the terms of the Merger Agreement, each restricted stock unit (including performance stock units) was canceled and converted into the right to receive an amount in cash equal to (i) the product of (A) the total number of Shares subject to (or deliverable under) such restricted stock unit (with any performance conditions deemed achieved at maximum levels with respect to any performance stock unit) multiplied by (B) the Cash Amount, and (ii) one CVR with respect to each Share subject to such restricted stock unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":40187},"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2341600,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":18.76,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2341599,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":27.36,"expiration_date":"2030-03-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2341598,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":52500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":10.2,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2341597,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":10.35,"expiration_date":"2026-03-13","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2341596,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":14250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":13.32,"expiration_date":"2025-10-04","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2341595,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"disposition_to_issuer","acquired":false,"shares":30289,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, (a) each outstanding option to purchase Shares (each, a \"Company Option\") with an exercise price less than $26.00 (each, an \"In the Money Option\"), was canceled and converted into the right to receive an amount in cash equal to, subject to applicable tax withholding, the product of (i) the excess, if any of the Cash Amount over the exercise price per Share underlying such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Options and one CVR; (b) each Company Option with an exercise price equal to or greater than $26.00 but less than $28.00 (each, an \"Out of the Money Option\"),"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"(Continued from Footnote 3) was canceled and converted into the right to receive, subject to the terms of the Merger Agreement, if and when (and only if and when) payments in respect of CVRs are required to be made, $28.00 in cash (less the applicable exercise price per Share subject to such Out of the Money Option); (c) each Company Option with an exercise price equal to or greater than $28.00, was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":13.96,"expiration_date":"2025-06-30","underlying":"Common Stock","underlying_shares":30289},"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2341594,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-09T19:10:31.000Z","date":"2022-03-07","kind":"other","acquired":false,"shares":16606,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 18, 2022, (the \"Merger Agreement\"), among UCB S.A., a societe anonyme formed under the laws of Belgium (\"Parent\"), Zinc Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (\"Purchaser\") and the Issuer, pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 7, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was canceled and converted into the right to receive $26.00 in cash (the \"Cash Amount\") plus a contingent value right (\"CVR\"), which CVR represents the right to receive a contingent payment of $2.00 which amount will become payable, if at all, if a specified milestone is achieved on or prior to December 31, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 1,830 Shares (as defined below) acquired under the Issuer's Employee Stock Purchase Plan since the last filing by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 18, 2022, (the \"Merger Agreement\"), among UCB S.A., a societe anonyme formed under the laws of Belgium (\"Parent\"), Zinc Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Parent (\"Purchaser\") and the Issuer, pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of March 7, 2022 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share was canceled and converted into the right to receive $26.00 in cash (the \"Cash Amount\") plus a contingent value right (\"CVR\"), which CVR represents the right to receive a contingent payment of $2.00 which amount will become payable, if at all, if a specified milestone is achieved on or prior to December 31, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-010301","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924322010301/doc4.xml","form_type":"4"}},{"id":2666897,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T16:32:47.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares subject to this grant dated June 15, 2021 shall vest on the day before the first year anniversary of the grant date."}],"balance_after":55000,"derivative":{"exercise_price":1.66,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-21-040923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000120919121040923/doc4.xml","form_type":"4"}},{"id":2669637,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T17:47:17.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":17438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full upon the earlier of June 10, 2022 or the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date."}],"balance_after":17438,"derivative":{"exercise_price":9.63,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":17438},"source":{"system":"sec-edgar","filing":"0001127602-21-019824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1614780/000112760221019824/form4.xml","form_type":"4"}},{"id":2767852,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-30T21:24:57.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ZGNX common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vests in four equal installments on each of March 15, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001375151-21-000036","document":"wf-form4_161715388469281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000036/wf-form4_161715388469281.xml","form_type":"4"}},{"id":2767851,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-30T21:24:57.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments, with the first vest date occurring on April 15, 2021, subject to the reporting person's continued service to the Company on the applicable vesting dates."}],"balance_after":30000,"derivative":{"exercise_price":18.76,"expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001375151-21-000036","document":"wf-form4_161715388469281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000036/wf-form4_161715388469281.xml","form_type":"4"}},{"id":2781760,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The restricted stock units vests in four equal installments on each of March 15, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Not applicable."}],"balance_after":4500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781759,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":2031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The restricted stock units vest in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Not applicable."}],"balance_after":4062,"derivative":{"underlying":"Common Stock","underlying_shares":2031},"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781758,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The restricted stock units vests in four equal installments on each of March 15, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Not applicable."}],"balance_after":1625,"derivative":{"underlying":"Common Stock","underlying_shares":1625},"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781757,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":542,"price":20.7,"value":11219.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F7","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 6."}],"balance_after":14776,"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781756,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 4, 2020."}],"balance_after":15318,"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781755,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":735,"price":20.7,"value":15214.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 4."}],"balance_after":13818,"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781754,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":2031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 22, 2019."}],"balance_after":14553,"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781753,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"tax_withholding","acquired":false,"shares":587,"price":20.7,"value":12150.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 1."}],"balance_after":12522,"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":2781752,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-03-17T16:02:22.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 305 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":13109,"source":{"system":"sec-edgar","filing":"0001375151-21-000020","document":"wf-form4_161601132751358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515121000020/wf-form4_161601132751358.xml","form_type":"4"}},{"id":3001917,"issuer":{"id":5328,"kind":"organization","name":"Tectonic Therapeutic, Inc.","symbol":"TECX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T16:24:19.000Z","date":"2020-10-19","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option shall vest and become exercisable in 36 equal monthly installments over a three-year period."}],"balance_after":28000,"derivative":{"exercise_price":16.14,"expiration_date":"2030-10-18","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001127602-20-027388","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1614780/000112760220027388/form4.xml","form_type":"4"}},{"id":3097477,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-29T21:54:08.000Z","date":"2020-06-25","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of ZGNX common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Restricted Stock Units (RSUs) were granted on March 14, 2017, with 100% of the RSUs to vest upon approval of the Company's New Drug Application (NDA) by the U.S. Food and Drug Administration for Fintepla. The NDA was approved on June 25, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001375151-20-000116","document":"wf-form4_159348200314523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000116/wf-form4_159348200314523.xml","form_type":"4"}},{"id":3097476,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:54:08.000Z","date":"2020-06-25","kind":"tax_withholding","acquired":false,"shares":3044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of RSUs described in footnote 1."}],"balance_after":11179,"source":{"system":"sec-edgar","filing":"0001375151-20-000116","document":"wf-form4_159348200314523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000116/wf-form4_159348200314523.xml","form_type":"4"}},{"id":3097475,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-06-29T21:54:08.000Z","date":"2020-06-25","kind":"exercise","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (RSUs) were granted on March 14, 2017, with 100% of the RSUs to vest upon approval of the Company's New Drug Application (NDA) by the U.S. Food and Drug Administration for Fintepla. The NDA was approved on June 25, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 425 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":14223,"source":{"system":"sec-edgar","filing":"0001375151-20-000116","document":"wf-form4_159348200314523.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000116/wf-form4_159348200314523.xml","form_type":"4"}},{"id":3105838,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-18T21:35:46.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total shares of this Grant Dated June 17, 2020 shall vest on the day before the first year anniversary of the Grant Date."}],"balance_after":55000,"derivative":{"exercise_price":2.33,"exercise_date":"2021-06-16","expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001082038-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000108203820000006/edgardoc.xml","form_type":"4"}},{"id":3150644,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-05-13T17:39:24.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":2573,"price":28.21,"value":72584.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":5048,"source":{"system":"sec-edgar","filing":"0001375151-20-000078","document":"wf-form4_158940594711843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000078/wf-form4_158940594711843.xml","form_type":"4"}},{"id":3204892,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-17T19:24:45.000Z","date":"2020-03-15","kind":"exercise","acquired":false,"shares":2032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The restricted stock units vest in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Not applicable."}],"balance_after":6093,"derivative":{"underlying":"Common Stock","underlying_shares":2032},"source":{"system":"sec-edgar","filing":"0001375151-20-000035","document":"wf-form4_158448746503630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000035/wf-form4_158448746503630.xml","form_type":"4"}},{"id":3204891,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-17T19:24:45.000Z","date":"2020-03-15","kind":"exercise","acquired":false,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The restricted stock units vests in four equal installments on each of March 15, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Not applicable."}],"balance_after":3250,"derivative":{"underlying":"Common Stock","underlying_shares":1625},"source":{"system":"sec-edgar","filing":"0001375151-20-000035","document":"wf-form4_158448746503630.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000035/wf-form4_158448746503630.xml","form_type":"4"}},{"id":3204890,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:24:45.000Z","date":"2020-03-15","kind":"tax_withholding","acquired":false,"shares":696,"price":22.01,"value":15318.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 4."}],"balance_after":7621,"source":{"system":"sec-edgar","filing":"0001375151-20-000035","document":"wf-form4_158448746503630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000035/wf-form4_158448746503630.xml","form_type":"4"}},{"id":3204889,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:24:45.000Z","date":"2020-03-15","kind":"exercise","acquired":true,"shares":2032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 22, 2019."}],"balance_after":8317,"source":{"system":"sec-edgar","filing":"0001375151-20-000035","document":"wf-form4_158448746503630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000035/wf-form4_158448746503630.xml","form_type":"4"}},{"id":3204888,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:24:45.000Z","date":"2020-03-15","kind":"tax_withholding","acquired":false,"shares":525,"price":22.01,"value":11555.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units described in footnote 1."}],"balance_after":6285,"source":{"system":"sec-edgar","filing":"0001375151-20-000035","document":"wf-form4_158448746503630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000035/wf-form4_158448746503630.xml","form_type":"4"}},{"id":3204887,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2020-03-17T19:24:45.000Z","date":"2020-03-15","kind":"exercise","acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 294 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":6810,"source":{"system":"sec-edgar","filing":"0001375151-20-000035","document":"wf-form4_158448746503630.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000035/wf-form4_158448746503630.xml","form_type":"4"}},{"id":3222412,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-06T16:08:48.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal installments on each of March 15, 2021, 2022, 2023 and 2024, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001375151-20-000023","document":"wf-form4_158352891140374.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000023/wf-form4_158352891140374.xml","form_type":"4"}},{"id":3222411,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T16:08:48.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2020, subject to the reporting person's continuous service to the Company on the applicable vesting dates."}],"balance_after":35000,"derivative":{"exercise_price":27.36,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001375151-20-000023","document":"wf-form4_158352891140374.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515120000023/wf-form4_158352891140374.xml","form_type":"4"}},{"id":3430137,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-08-23T16:09:02.000Z","date":"2019-08-22","kind":"sale","acquired":false,"shares":3446,"price":52,"value":179192.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale transaction reported in this Form 4 was made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":4891,"source":{"system":"sec-edgar","filing":"0001375151-19-000115","document":"wf-form4_156659092636188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000115/wf-form4_156659092636188.xml","form_type":"4"}},{"id":3549219,"issuer":{"id":75335,"kind":"organization","name":"DURECT CORP","symbol":"DRRX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-04-25T20:14:27.000Z","date":"2019-04-23","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the total number of shares vesting and becoming exercisable on each anniversary of the grant."}],"balance_after":70000,"derivative":{"exercise_price":0.5684,"exercise_date":"2020-04-23","expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001082038-19-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082038/000108203819000010/edgardoc.xml","form_type":"4"}},{"id":3578309,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-26T16:11:34.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":8125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vests in four equal installments on each of March 15, 2020, 2021, 2022 and 2023, subject to the reporting person's continuous service to the Company on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":8125,"derivative":{"underlying":"Common Stock","underlying_shares":8125},"source":{"system":"sec-edgar","filing":"0001375151-19-000042","document":"wf-form4_155363108036278.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000042/wf-form4_155363108036278.xml","form_type":"4"}},{"id":3578308,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-26T16:11:34.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":63750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2019, subject to the reporting person's continued service to the Company on the applicable vesting dates."}],"balance_after":63750,"derivative":{"exercise_price":52.66,"expiration_date":"2029-03-22","underlying":"Common Stock","underlying_shares":63750},"source":{"system":"sec-edgar","filing":"0001375151-19-000042","document":"wf-form4_155363108036278.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000042/wf-form4_155363108036278.xml","form_type":"4"}},{"id":3586279,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-19T18:59:29.000Z","date":"2019-03-15","kind":"exercise","acquired":false,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":4875,"derivative":{"underlying":"Common Stock","underlying_shares":1625},"source":{"system":"sec-edgar","filing":"0001375151-19-000033","document":"wf-form4_155303635426279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000033/wf-form4_155303635426279.xml","form_type":"4"}},{"id":3586278,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-03-19T18:59:29.000Z","date":"2019-03-15","kind":"tax_withholding","acquired":false,"shares":488,"price":51.88,"value":25317.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock units granted to the Reporting Person."}],"balance_after":8337,"source":{"system":"sec-edgar","filing":"0001375151-19-000033","document":"wf-form4_155303635426279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000033/wf-form4_155303635426279.xml","form_type":"4"}},{"id":3586277,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2019-03-19T18:59:29.000Z","date":"2019-03-15","kind":"exercise","acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents vesting of one-fourth (1/4) of restricted stock units granted on March 15, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 57 shares acquired under the Company's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":8825,"source":{"system":"sec-edgar","filing":"0001375151-19-000033","document":"wf-form4_155303635426279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515119000033/wf-form4_155303635426279.xml","form_type":"4"}},{"id":3794237,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-09T17:37:48.000Z","date":"2018-10-04","kind":"exercise","acquired":false,"shares":6961,"price":13.96,"value":97175.56,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was granted on July 1, 2015, which is the vesting commencement date. One-fourth of the shares subject to the option will vest on the first anniversary of the vesting commencement date, and the remaining shares subject to the option shall vest in thirty-six equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment with the Company on each vesting date."}],"balance_after":30289,"derivative":{"exercise_price":13.96,"expiration_date":"2025-06-30","underlying":"Common Stock","underlying_shares":6961},"source":{"system":"sec-edgar","filing":"0001375151-18-000074","document":"wf-form4_153912105220309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000074/wf-form4_153912105220309.xml","form_type":"4"}},{"id":3794236,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-10-09T17:37:48.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":1961,"price":43.7356,"value":85765.5116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $43.22 to $44.70, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":7143,"source":{"system":"sec-edgar","filing":"0001375151-18-000074","document":"wf-form4_153912105220309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000074/wf-form4_153912105220309.xml","form_type":"4"}},{"id":3794235,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-10-09T17:37:48.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":2900,"price":43.1123,"value":125025.67,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $43.04 to $43.19, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":9104,"source":{"system":"sec-edgar","filing":"0001375151-18-000074","document":"wf-form4_153912105220309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000074/wf-form4_153912105220309.xml","form_type":"4"}},{"id":3794234,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-10-09T17:37:48.000Z","date":"2018-10-04","kind":"sale","acquired":false,"shares":2100,"price":42.9224,"value":90137.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $42.65 to $43.03, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":12004,"source":{"system":"sec-edgar","filing":"0001375151-18-000074","document":"wf-form4_153912105220309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000074/wf-form4_153912105220309.xml","form_type":"4"}},{"id":3794233,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-10-09T17:37:48.000Z","date":"2018-10-04","kind":"exercise","acquired":true,"shares":6961,"price":13.96,"value":97175.56,"ownership":{"direct":true},"balance_after":14104,"source":{"system":"sec-edgar","filing":"0001375151-18-000074","document":"wf-form4_153912105220309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000074/wf-form4_153912105220309.xml","form_type":"4"}},{"id":3825218,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-05T16:14:15.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":7000,"price":13.96,"value":97720.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on July 1, 2015, which is the vesting commencement date. One-fourth of the shares subject to the option will vest on the first anniversary of the vesting commencement date, and the remaining shares subject to the option shall vest in thirty-six equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment with the Company on each vesting date"}],"balance_after":37250,"derivative":{"exercise_price":13.96,"expiration_date":"2025-06-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001375151-18-000068","document":"wf-form4_153617843899070.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000068/wf-form4_153617843899070.xml","form_type":"4"}},{"id":3825217,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-09-05T16:14:15.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":2300,"price":48.2054,"value":110872.42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $47.95 to $48.35, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":7143,"source":{"system":"sec-edgar","filing":"0001375151-18-000068","document":"wf-form4_153617843899070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000068/wf-form4_153617843899070.xml","form_type":"4"}},{"id":3825216,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-09-05T16:14:15.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":4700,"price":47.2702,"value":222169.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $46.90 to $47.85, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":9443,"source":{"system":"sec-edgar","filing":"0001375151-18-000068","document":"wf-form4_153617843899070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000068/wf-form4_153617843899070.xml","form_type":"4"}},{"id":3825215,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-09-05T16:14:15.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":7000,"price":13.96,"value":97720.0,"ownership":{"direct":true},"balance_after":14143,"source":{"system":"sec-edgar","filing":"0001375151-18-000068","document":"wf-form4_153617843899070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000068/wf-form4_153617843899070.xml","form_type":"4"}},{"id":3847314,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-10T16:06:22.000Z","date":"2018-08-08","kind":"exercise","acquired":false,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was granted on July 1, 2015, which is the vesting commencement date. One-fourth of the shares subject to the option will vest on the first anniversary of the vesting commencement date, and the remaining shares subject to the option shall vest in thirty-six equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment with the Company on each vesting date."}],"balance_after":44250,"derivative":{"exercise_price":13.96,"expiration_date":"2025-06-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001375151-18-000065","document":"wf-form4_153393156441280.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000065/wf-form4_153393156441280.xml","form_type":"4"}},{"id":3847313,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-08-10T16:06:22.000Z","date":"2018-08-08","kind":"sale","acquired":false,"shares":1900,"price":53.1553,"value":100995.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $52.95 to $53.53, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":7143,"source":{"system":"sec-edgar","filing":"0001375151-18-000065","document":"wf-form4_153393156441280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000065/wf-form4_153393156441280.xml","form_type":"4"}},{"id":3847312,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-08-10T16:06:22.000Z","date":"2018-08-08","kind":"sale","acquired":false,"shares":5100,"price":52.4152,"value":267317.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.These shares were sold in multiple transactions at prices ranging from $51.95 to $52.90, inclusive.The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":9043,"source":{"system":"sec-edgar","filing":"0001375151-18-000065","document":"wf-form4_153393156441280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000065/wf-form4_153393156441280.xml","form_type":"4"}},{"id":3847311,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-08-10T16:06:22.000Z","date":"2018-08-08","kind":"exercise","acquired":true,"shares":7000,"price":13.96,"value":97720.0,"ownership":{"direct":true},"balance_after":14143,"source":{"system":"sec-edgar","filing":"0001375151-18-000065","document":"wf-form4_153393156441280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000065/wf-form4_153393156441280.xml","form_type":"4"}},{"id":3895278,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-13T20:57:56.000Z","date":"2018-06-12","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted on July 1, 2015, which is the vesting commencement date. One-fourth of the shares subject to the option will vest on the first anniversary of the vesting commencement date, and the remaining shares subject to the option shall vest in thirty-six equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment with the Company on each vesting date"}],"balance_after":51250,"derivative":{"exercise_price":13.96,"expiration_date":"2025-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001375151-18-000050","document":"wf-form4_152893786064891.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000050/wf-form4_152893786064891.xml","form_type":"4"}},{"id":3895277,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-06-13T20:57:56.000Z","date":"2018-06-12","kind":"sale","acquired":false,"shares":5118,"price":45,"value":230310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2018."}],"balance_after":7143,"source":{"system":"sec-edgar","filing":"0001375151-18-000050","document":"wf-form4_152893786064891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000050/wf-form4_152893786064891.xml","form_type":"4"}},{"id":3895276,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Common Stock","published_at":"2018-06-13T20:57:56.000Z","date":"2018-06-12","kind":"exercise","acquired":true,"shares":5000,"price":13.96,"value":69800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,261 shares of common stock previously purchased by the Reporting Person pursuant to the Issuer's employee stock purchase plan."}],"balance_after":12261,"source":{"system":"sec-edgar","filing":"0001375151-18-000050","document":"wf-form4_152893786064891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000050/wf-form4_152893786064891.xml","form_type":"4"}},{"id":3992195,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-16T16:17:34.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Zogenix common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest as to 1/4th of the original number of shares subject to the restricted stock unit award on the one-year anniversary of the date of grant, and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each of the following three anniversaries, subject to the reporting person's continued service with the Issuer on the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":6500,"derivative":{"underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001375151-18-000017","document":"wf-form4_152123144012793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000017/wf-form4_152123144012793.xml","form_type":"4"}},{"id":3992194,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-16T16:17:34.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest in a series of forty-eight (48) successive, equal monthly installments beginning on April 15, 2018, subject to the reporting person's continued service with the Issuer on the applicable vesting dates."}],"balance_after":40000,"derivative":{"exercise_price":42.65,"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001375151-18-000017","document":"wf-form4_152123144012793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000137515118000017/wf-form4_152123144012793.xml","form_type":"4"}},{"id":4382237,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Restricted Stock Units","published_at":"2017-03-16T20:00:41.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ZGNX common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest upon the approval by the U.S. Food and Drug Administration of the Company's New Drug Application for ZX008, provided such approval occurs within five years following the grant date, subject to the option recipient's continuous service to the Company on such vesting date."}],"balance_after":8750,"derivative":{"expiration_date":"2022-03-13","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0000899243-17-007842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924317007842/doc4.xml","form_type":"4"}},{"id":4382236,"issuer":{"id":129305,"kind":"organization","name":"ZOGENIX, INC.","symbol":"ZGNX"},"owners":[{"id":75466,"kind":"person","name":"Farfel Gail M","position":1,"cik":"0001614780","reported_name":"Farfel Gail M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP/Chief Development Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-16T20:00:41.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on March 14, 2017 and vests in a series of forty-eight (48) successive, equal monthly installments beginning on April 14, 2017, subject to the reporting person's continued employment with the Company on each vesting date."}],"balance_after":52500,"derivative":{"exercise_price":10.2,"expiration_date":"2027-03-13","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0000899243-17-007842","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375151/000089924317007842/doc4.xml","form_type":"4"}}]}